7 citations · 7 across the 1 of their papers we have counts for
2 papers
stat.ME2022★ 7 cited
Quantification of follow-up time in oncology clinical trials with a time-to-event endpoint: Asking the right questions
Kaspar Rufibach, Lynda Grinsted, Jiang Li +3
For the analysis of a time-to-event endpoint in a single-arm or randomized clinical trial it is generally perceived that interpretation of a given estimate of the survival function…
stat.ME2019
A Simulation-free Group Sequential Design with Max-combo Tests in the Presence of Non-proportional Hazards
Lili Wang, Xiaodong Luo, Cheng Zheng
Non-proportional hazards (NPH) have been observed recently in many immuno-oncology clinical trials. Weighted log-rank tests (WLRT) with suitably chosen weights can be used to impro…